HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase
about
Effect of lovastatin on coxsackievirus B3 infection in human endothelial cellsDifferential effects of Losartan and Atorvastatin in partial and full thickness burn woundsEffects of rosuvastatin on ADMA, rhokinase, NADPH oxidase, caveolin-1, hsp 90 and NFkB levels in a rat model of myocardial ischaemia-reperfusion.Vascular Nitric Oxide: Formation and Function.Endothelial relaxation mechanisms and oxidative stress are restored by atorvastatin therapy in ovariectomized rats.Rosuvastatin prevents proteinuria and renal inflammation in nitric oxide-deficient ratsFatal rhabdomyolysis in a patient with liver cirrhosis after switching from simvastatin to fluvastatin.Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy.Early treatment with atorvastatin exerts parenchymal and vascular protective effects in experimental cerebral ischaemiaRosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction.Low-dose atorvastatin, losartan, and particularly their combination, provide cardiovascular protection in isolated rat heart and aorta.Simvastatin enhances the antihypertensive effect of ramipril in hypertensive hypercholesterolemic animals and patients. Possible role of nitric oxide, oxidative stress, and high sensitivity C-reactive protein.
P2860
Q28303547-799B2A91-4F41-4E27-AC50-1E720D39E852Q33797407-2427576A-B5A8-4198-ABB7-8ACEC3EDADCEQ34562019-2AD65817-7A36-49B6-B1DD-AA48A5B2F8A8Q34973956-3AEB44D5-F221-4144-A4F0-E3086C0CE4D0Q35053761-7183CF1E-09C5-4EFB-85EE-25BF291A25DCQ35179736-EF5C8D84-BF45-417C-90A3-30C5F46FBDA8Q35590662-A3940875-3F1C-4473-A3ED-E0AFDBDC29ACQ37881801-EA15CAA5-7E69-4126-96F0-A9BFA1372B12Q40625919-8B98C5E3-CC95-4EBC-A86C-AEEDDF6ABF85Q42986839-A8DA2612-CFE4-4DED-ADB8-4BB0FFDB8267Q46064003-9916E753-28DF-45A4-BCF0-32712B95DBC4Q46151507-8A2642FA-7867-4BA5-83AD-C4A4E1AE6350
P2860
HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
HMG-CoA reductase inhibitor im ...... othelial nitric oxide synthase
@ast
HMG-CoA reductase inhibitor im ...... othelial nitric oxide synthase
@en
HMG-CoA reductase inhibitor im ...... thelial nitric oxide synthase.
@nl
type
label
HMG-CoA reductase inhibitor im ...... othelial nitric oxide synthase
@ast
HMG-CoA reductase inhibitor im ...... othelial nitric oxide synthase
@en
HMG-CoA reductase inhibitor im ...... thelial nitric oxide synthase.
@nl
prefLabel
HMG-CoA reductase inhibitor im ...... othelial nitric oxide synthase
@ast
HMG-CoA reductase inhibitor im ...... othelial nitric oxide synthase
@en
HMG-CoA reductase inhibitor im ...... thelial nitric oxide synthase.
@nl
P2093
P2860
P1476
HMG-CoA reductase inhibitor im ...... othelial nitric oxide synthase
@en
P2093
Cheol-Ho Kim
Dong-Ju Choi
Hyo-Soo Kim
In-Ho Chae
Jung-Won Suh
Kwang-Il Kim
Tae-Jin Youn
Young-Bae Park
Young-Seok Cho
P2860
P356
10.3346/JKMS.2010.25.1.16
P577
2009-12-26T00:00:00Z